FARALLON CAPITAL MANAGEMENT LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$107,788,228
-1.9%
4,481,839
+30.2%
0.54%
-5.4%
Q2 2023$109,887,797
+4.6%
3,441,522
+0.3%
0.57%
-1.7%
Q1 2023$105,085,421
-21.0%
3,431,921
+0.9%
0.58%
-26.8%
Q4 2022$132,970,910
-23.1%
3,399,921
-6.4%
0.79%
-17.0%
Q3 2022$172,994,000
+28.7%
3,631,271
+4.6%
0.96%
+30.6%
Q2 2022$134,412,000
-9.6%
3,472,271
+33.8%
0.73%
+2.1%
Q1 2022$148,658,000
-17.6%
2,594,387
+14.5%
0.72%
-20.4%
Q4 2021$180,501,000
+20.8%
2,265,045
+31.9%
0.90%
+29.2%
Q3 2021$149,448,000
-22.6%
1,717,590
+14.5%
0.70%
-11.4%
Q2 2021$193,065,000
+307.1%
1,500,000
+153.2%
0.79%
+233.9%
Q1 2021$47,422,000
+1448.2%
592,481
+248.2%
0.24%
+807.7%
Q1 2020$3,063,000170,1640.03%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders